Clinical Trial Update: Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS [Phase 3]

View source ↗

Summary

Phase 3 trial comparing trimetrexate with leucovorin rescue to sulfamethoxazole-trimethoprim for Pneumocystis jirovecii pneumonia (PCP) in AIDS patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Pneumocystis Pneumonia

Drugs mentioned

• Sulfamethoxazole-trimethoprim (sulfamethoxazole-trimethoprim)
• Trimetrexate plus leucovorin calcium rescue (trimetrexate)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED